复星医药 (600196.sh)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(复星医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 10,157,255,262.4041,399,539,588.4230,700,119,056.1221,395,192,579.8810,870,720,838.6643,951,546,895.2331,610,071,303.1921,340,053,678.4210,381,939,406.19
 营业利润(元) 1,021,364,060.983,307,507,905.123,342,197,770.862,682,610,757.241,427,139,292.414,656,656,381.283,592,532,812.592,546,739,726.09895,946,662.77
 利润总额(元) 1,018,423,857.093,264,567,878.743,292,456,489.612,655,469,971.171,384,764,032.274,574,381,584.813,402,844,007.582,372,410,505.32887,647,050.27
 净利润(元) 786,221,155.862,895,063,426.582,653,809,536.672,045,225,278.441,114,254,110.163,947,464,120.112,791,304,302.371,863,325,047.77644,285,309.19
 归属于母公司股东的净利润(元) 609,733,627.262,386,265,813.742,283,065,930.631,777,471,869.71986,971,662.493,730,804,582.822,454,367,005.071,547,333,556.86462,512,220.54
盈利能力:
 销售毛利率(%) 50.0147.8448.6050.0051.2947.2846.5145.7643.55
 销售净利率(%) 7.746.998.649.5610.258.988.838.736.21
 净资产收益率(%) 1.335.295.104.252.36----
 总资产报酬率ROA(%) 1.173.853.763.031.62----
 投入资本回报率ROIC(%) 0.763.092.962.291.305.393.582.350.72
营运能力:
 存货周转率(次) 0.683.002.141.530.80----
 应收账款周转率(次) 1.335.444.072.651.53----
 总资产周转率(次) 0.090.380.290.200.11----
偿债能力:
 资产负债率(%) 49.4250.1049.4650.5648.7449.5148.9851.6950.13
 股东权益比率(%) 40.7540.2641.4640.5442.2741.6041.7238.6640.02
 已获利息倍数(倍) 4.634.325.355.876.308.0710.0110.069.31
 流动比率 1.011.001.011.001.081.061.101.011.02
 速动比率 0.740.730.740.750.790.790.820.740.75
发展能力:
 营业收入增长率(%) -6.56-5.81-2.920.224.6812.6616.8725.8828.87
 营业利润增长率(%) -28.43-28.97-6.146.1761.11-26.11-23.55-23.47-22.73
 税后利润增长率(%) -38.22-36.04-6.2915.74116.17-21.10-31.15-37.67-45.41
 净资产增长率(%) 2.102.475.5019.0118.4313.7411.780.891.67
 总资产增长率(%) 5.935.886.1713.5012.1214.8515.5311.6710.58

前瞻产业研究院